BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04956692-completion@plaintrial.com
DTSTAMP:20261028T203359Z
DTSTART;VALUE=DATE:20261014
SUMMARY:Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembroliz
 umab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in P
 articipants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Ca
 ncer (NSCLC) (MK-3475-A86) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04956692
URL:https://plaintrial.com/trial/NCT04956692
END:VEVENT
END:VCALENDAR